08:30 - 10:00 a.m.	CEO Breakfast - What's hot in Australian biotech
10:30 - 12:00 noon	Connecting the Dots between Australian and United States biotech
12:00 - 2:00 p.m.	Lunch time Keynote Address: Professor Ian Frazer From Bench to Shelf ­ the Gardasil story
2:00 - 3:30 p.m.	Australian biotech innovation
3:45 - 5:15 p.m.	Let's Make a Deal - finance and investment options for international transactions
6:30 - 8:30 p.m.	Cocktail Reception at the Exchange Conference Center featuring premium Australian wines

Introducer: Bruce L. Rogers Ph.D., Conference Chairman, American Australian Association of New England Moderator: Dr. Anna Lavelle, CEO Ausbiotech

Presenters: • Mel Bridges, Chairman, Peptech • Sue MacLeman, CEO, Benitec Ltd • Michael Aldridge, CEO, Peplin Ltd • Garry Redlich, CEO & Managing Director, Implicit Bioscience Pty Ltd • Dr. Mikael Hirsch, CSIRO

Australia's leading biotech CEO's present on: • the hottest developments in their industries • how they are leveraging their unique assets to bring new products and capabilities to market

CEO's presentations are followed by a Q & A session.


• Charles Grant, Chairman, American Australian Association, New England
• Peter Chaffey, City of Melbourne, Australia

Introducer:	Michael Levy, VP Alliance Management, Bristol-Myers Squibb
Presenters: • Dr. Greg Collier, CEO, ChemGenex Pharmaceuticals • Dr. Gangfeng Xu, Sr. Director, Head of Business and Licensing, Wyeth • Dr. Ivana Magovcevic-Liebisch, General Counsel and EVP, Dyax Corp. • Dr. Igor Gonda, President & CEO, Aradigm

The Connecting the Dots Panel will discuss how the hottest Australian companies are successfully translating their technologies to the international market and the vehicles chosen for collaboration.

This moderated panel will discuss exciting new technologies and business models that advance the drug discovery and development process.

Introducer: Barry Jones, CEO Invest Australia

Keynote speaker: Professor Ian Frazer- Australian of the Year 2006

	"From research bench to shelf – the Gardasil story"

Professor Frazer, named Australian of the Year 2006 for his work on the human papilloma virus, laid the groundwork for the development of vaccines to prevent infections caused by the virus as well as cervical cancer.

After the keynote address, a panel of senior pharmaceutical and life sciences representatives will discuss how world-class Australian research is being commercialized and marketed through global partnerships. Panel members are:

• Barbara Yanni, Vice President and Chief Licensing Officer, Merck & Co., Inc.
• William Griffith, Practice Group Leader, Life Sciences Transaction Group, Reed Smith LLP.
• Professor Susan Pond, Chairman, AusBiotech

2:00 - 3:30 p.m. Australian biotech innovation

Introducer: Dr. Anna Lavelle, CEO Ausbiotech Moderator: Dr. Bruce Pratt, VP Science Development, Genzyme Corporation

Presenters: • Professor Stephen Livesey, CEO, The Australian Stem Cell Centre • Justus Homberg, CEO Progen • Dr. Peter Smith, CEO, Alchemia • Dr. Alex Szabo, VP Business Development, Bionomics • Katerina Karanikolopoulos, VP Business Development Phosphagenics Ltd

This session will showcase top Australian companies highlighting the opportunities Australia offers and the value for global biotechnology and pharmaceutical companies. Company presentations followed by Q & A.

Exchange Conference Center 212 Northern Avenue on Boston's historic waterfront.

Featuring a selection of fine Australian wines

* Transport to the Exchange Conference Center from the DoubleTree Hotel available for attendees, bus departs at 5.45pm and 6pm